Dexcom grows revenues 18% in Q1, raises guidance
Dexcom (Nasdaq:DXCM) today announced that it's raising its 2023 financial guidance following strong first-quarter financial results.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dexcom (Nasdaq:DXCM) today announced that it's raising its 2023 financial guidance following strong first-quarter financial results.
ResMed [WtwhTicker symbol=“RMD”] (NYSE:RMD) [/WtwhTicker] shares ticked up today on third-quarter results that topped the consensus forecast.
Edwards Lifesciences (NYSE:EW) shares dipped after hours today despite first-quarter results that topped the consensus forecast.
Baxter [WtwhTicker symbol='BAX'](NYSE: BAX)[/WtwhTicker] shares ticked up today on first-quarter results that beat the consensus forecast.
Integra LifeSciences (Nasdaq:IART)shares dipped today despite first-quarter results that beat the consensus revenue forecast.